00000nam 2200000zi 4500 9.884461 CaOODSP 20231208122544 m o d f cr |n||||||||| 200210t20202020onc ob f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- H113-27/2020-2E-PDF H113-27/2020-2E Cyromazine and its associated end-use products : consultation document. Ottawa, Ontario : Pest Management Regulatory Agency, Health Canada, 2020. ©2020 1 online resource (137 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Proposed re-evaluation decision, 1925-0967 ; PRVD2020-02 Issued also in French under title: Cyromazine et préparations commerciales connexes : document de consultation. Cover title. "5 February 2020." Includes bibliographical references (pages 115-137). "This document presents the proposed regulatory decision for the re-evaluation of cyromazine including the proposed risk mitigation measures to further protect human health and the environment, as well as the science evaluation on which the proposed decision was based. All products containing cyromazine registered in Canada are subject to this proposed re-evaluation decision. This document is subject to a 90-day public consultation period, during which the public including the pesticide manufacturers and stakeholders may submit written comments and additional information to the PMRA. The final re-evaluation decision will be published taking into consideration the comments and information received"--page 1. Insecticides Certification Canada. Insecticides Toxicology. Insecticides Environmental aspects. Canada. Health Canada. Canada. Pest Management Regulatory Agency. Cyromazine et préparations commerciales connexes : (CaOODSP)9.884465 Proposed re-evaluation decision (Canada. Pest Management Regulatory Agency) PRVD2020-02. (CaOODSP)9.505201 PDF 1.17 MB https://publications.gc.ca/collections/collection_2020/sc-hc/h113-27/H113-27-2020-2-eng.pdf (report)